Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Vir Biotechnology has appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026 ...

A Bay Area biotech company appears to be one major step closer to receiving final federal approval for its groundbreaking ...

Diversification via an ETF can help biotech investors avoid boom-or-bust volatility while still capitalizing on long-term growth trends.

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "USA Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The new USA Directory of Biotechnology Companies is ...

While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...

VitroVivo Biotech LLC, a Maryland-based provider of histology and molecular histopathology products and laboratory services, is expanding access to specialized tissue-based research support through ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

(Nasdaq: VIR) today announced the appointment of Aziz Sawaf, MBEE, MBA, CFA, as Executive Vice President and Chief Financial ...

Laneige-owner Amorepacific has made a strategic investment in biotechnology company Junevity to utilise its RESET Platform – ...

A Waltham-based biotech company is preparing to lay off about 75% of its staff, or 96 people, after it failed to secure key funding for a clinical trial. TScan Therapeutics will conduct the mass ...